UBS cut Laopu Gold (06181.HK) PT to HK$650 from HK$930 and reiterated a Buy rating. The bank says boutique upgrades, VIC services and more frequent new-product launches enhance the company’s brand, channel and product positioning, helping cushion a gold-price pullback. UBS views the shares as oversold and cites potential catalysts including stronger-than-expected 1H results, VIC-related activity and H2 overseas store openings; it forecasts 1H revenue and net profit up about 93% and 118% YoY. UBS

杰富瑞：将纽蒙特矿业(NEM.N)目标价从158美元下调至146美元。

Huatai Securities says near-term focus should be on Hong Kong names that are deeply oversold, carry heavy short interest and show marginal stabilization or improvement in earnings expectations—notably innovative drugmakers and electric utilities—and on high-dividend defensive banks. Innovative-drug fundamentals are still improving; global style rebalancing has triggered catch-up moves and short-covering may continue. Prioritise CXO names with positive guidance and leading drugmakers with strong BD potential. For the AI hardware chain, further near-term increases offer limited risk/reward; the next critical window is the US July earnings season, so adjust exposure according to unrealized gains. AI software is more a source of stock-specific alpha tied to model leadership. On a medium-term view, maintain a balanced allocation between sectors showing accelerating demand and undervalued reversal candidates.